Search

everythinglearnresearchcommunity

for

Search:↓

AGA is a common hair loss affecting both genders, treated with various therapies to promote regrowth and slow thinning.

Minoxidil, finasteride, and hair transplantation combined give best results for hair loss.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

AGA causes hair loss by shrinking hair follicles due to DHT binding, and can be treated with finasteride and minoxidil.

PGD2 stops hair growth and is higher in bald men with AGA.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

Male pattern baldness involves genetics, hormones, and needs better treatments.

Use minoxidil for hair loss treatment; assess results after 6 months.

Too much androgen can cause hair loss; finasteride may help.

Stem cell therapy, particularly using certain types of cells, shows promise for treating hair loss by stimulating hair growth and development, but more extensive trials are needed to confirm these findings.

Most women with hirsutism or androgenic alopecia had polycystic ovaries, especially if they had irregular periods.

Skin grafts on mice can cause an immune response leading to hair loss, useful for studying human hair loss conditions.

The telogen phase of hair growth is active and important for preparing hair follicles for regeneration, not just a resting stage.

Hair loss occurs due to fewer papillary cells, smaller follicles, and shorter growth phases.

Minoxidil and finasteride can slow hair loss and stimulate regrowth, but won't restore all lost hair or reverse complete baldness.

Hair loss linked to higher heart disease risk in both men and women.

Oxidative stress affects hair loss in men with androgenetic alopecia.

Using nanostructured lipid carriers to deliver spironolactone could improve treatment for hair loss.

Using human fat tissue derived stem cells in micrografts can safely and effectively increase hair density in people with hair loss.

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.

CCCA is a hair loss type affecting African women, possibly caused by grooming and chemicals, with various treatments and needing more research.

Mice lacking a key DNA methylation enzyme in skin cells have a lower chance of activating stem cells necessary for hair growth, leading to progressive hair loss.

AGA can occur in children with family history; early diagnosis and treatment important.

Minoxidil and finasteride treat hair loss; more research needed for other options.

Genetic differences may affect COVID-19 deaths; anti-androgens could be potential treatment.

Hair loss from hormone therapy in breast cancer patients can be improved with minoxidil treatment.

The document concludes that alopecia areata is an autoimmune disease without a definitive cure, but treatments like corticosteroids are commonly used.

PRP treatment may increase hair density and reduce hair loss, but more research is needed.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

Researchers found a white halo around hair in most patients with a specific type of hair loss, which helps in early diagnosis and treatment.